These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9438393)
1. Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors. De Vita G; Zannini M; Cirafici AM; Melillo RM; Di Lauro R; Fusco A; Santoro M Cell Growth Differ; 1998 Jan; 9(1):97-103. PubMed ID: 9438393 [TBL] [Abstract][Full Text] [Related]
2. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903 [TBL] [Abstract][Full Text] [Related]
3. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638 [TBL] [Abstract][Full Text] [Related]
4. Thyroid-specific gene expression is differentially influenced by intracellular glutathione level in FRTL-5 cells. Lonigro R; Donnini D; Fabbro D; Perrella G; Damante G; Ambesi Impiombato FS; Curcio F Endocrinology; 2000 Mar; 141(3):901-9. PubMed ID: 10698164 [TBL] [Abstract][Full Text] [Related]
5. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822 [TBL] [Abstract][Full Text] [Related]
6. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases. Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606 [TBL] [Abstract][Full Text] [Related]
7. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191 [TBL] [Abstract][Full Text] [Related]
8. Thyroid carcinomas in RET/PTC transgenic mice. Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006 [TBL] [Abstract][Full Text] [Related]
9. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Fabbro D; Di Loreto C; Beltrami CA; Belfiore A; Di Lauro R; Damante G Cancer Res; 1994 Sep; 54(17):4744-9. PubMed ID: 8062273 [TBL] [Abstract][Full Text] [Related]
10. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. Castellone MD; Cirafici AM; De Vita G; De Falco V; Malorni L; Tallini G; Fagin JA; Fusco A; Melillo RM; Santoro M Oncogene; 2003 Jan; 22(2):246-55. PubMed ID: 12527893 [TBL] [Abstract][Full Text] [Related]
11. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma. Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832 [TBL] [Abstract][Full Text] [Related]
12. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. Cetta F; Chiappetta G; Melillo RM; Petracci M; Montalto G; Santoro M; Fusco A J Clin Endocrinol Metab; 1998 Mar; 83(3):1003-6. PubMed ID: 9506763 [TBL] [Abstract][Full Text] [Related]
13. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225 [TBL] [Abstract][Full Text] [Related]
14. Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Kambe F; Nomura Y; Okamoto T; Seo H Mol Endocrinol; 1996 Jul; 10(7):801-12. PubMed ID: 8813721 [TBL] [Abstract][Full Text] [Related]
15. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913 [TBL] [Abstract][Full Text] [Related]
16. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Ros P; Rossi DL; Acebrón A; Santisteban P Biochimie; 1999 Apr; 81(4):389-96. PubMed ID: 10401674 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha regulation of thyroid transcription factor-1 and Pax-8 in rat thyroid FRTL-5 cells. Ohmori M; Harii N; Endo T; Onaya T Endocrinology; 1999 Oct; 140(10):4651-8. PubMed ID: 10499522 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines. Chun YS; Saji M; Zeiger MA Surgery; 1998 Dec; 124(6):1100-5. PubMed ID: 9854590 [TBL] [Abstract][Full Text] [Related]
20. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas. Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]